Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2022 Jul 25;22:813. doi: 10.1186/s12885-022-09907-4

Correction: CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma

Yozo Mitsui 1,2,✉,#, Inik Chang 3,4,#, Shinichiro Fukuhara 4, Miho Hiraki 1, Naoko Arichi 1, Hiroaki Yasumoto 1, Hiroshi Hirata 2, Soichiro Yamamura 2, Varahram Shahryari 2, Guoren Deng 2, Darryn K Wong 2, Shahana Majid 2, Hiroaki Shiina 1, Rajvir Dahiya 2, Yuichiro Tanaka 2,
PMCID: PMC9310497  PMID: 35879687

Correction: BMC Cancer 15, 942 (2015)

https://doi.org/10.1186/s12885-015-1951-0

Following publication of the original article [1], the authors identified an error in Fig. 2C.

Fig. 2.

Fig. 2

c Representative images of wound healing assay. After siRNA transfection for 48 h, a wound was formed by scraping and closure of wound measured after 24 h. Attenuation of CYP1B1 significantly inhibited cell migration. **, P < 0.01.***, P < 0.001

In Fig. 2C, the wrong image representing wound healing in CYP1B1-siRNA#1-treated Caki-1 cells at 0 hours was inadvertently applied. Although the wrong image was mistakenly utilized, results are essentially the same and does not change the outcome or conclusions of the article. The correct Fig. 2C is given in this correction article.

Footnotes

Yozo Mitsui and Inik Chang contributed equally to this work.

Contributor Information

Yozo Mitsui, Email: mitsui@med.shimane-u.ac.jp.

Yuichiro Tanaka, Email: Yuichiro.tanaka@ucsf.edu.

Reference

  • 1.Mitsui Y, Chang I, Fukuhara S, et al. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC Cancer. 2015;15:942. doi: 10.1186/s12885-015-1951-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES